Recombinant humanized anti-CD-47 monoclonal antibody (Shandong New Time Pharmaceutical)
重组人源化抗CD47单克隆抗体（山东新时代药业）
Report date: 2023/07/31 20:00:35
Base Information
Drug NameRecombinant humanized anti-CD-47 monoclonal antibody (Shandong New Time Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShandong New Time Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesShandong New Time Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A